Breast cancer surgical services in South Africa: Availability and barriers to guideline-concordant care
DOI:
https://doi.org/10.7196/SAMJ.2025.v116i3.3154Keywords:
Breast cancer, Global surgery, Surgery, South AfricaAbstract
Background. Female breast cancer has become the most frequently diagnosed cancer globally. The incidence of cancer in South Africa (SA) is projected to double by 2030, and services to address the growing burden of disease are urgently needed. The distribution and capacity of existing breast cancer surgical services in SA haVE not been reported.
Objective. To provide a quantitative descriptive analysis of the status of breast cancer surgical services in the public healthcare sector in SA.
Methods. A descriptive cross-sectional analysis of breast cancer surgical services was performed, including the burden of disease, stage of diagnosis, available diagnostic and therapeutic modalities, waiting time to surgery and barriers to care. Clinicians at every public sector healthcare facility providing surgical care to breast cancer patients were approached to complete a quantitative survey for the year 2019.
Results. Data from 43 hospitals across all nine SA provinces were included. Clinicians reported a greater proportion of late-stage breast cancer (67%) than early breast cancer (33%) at diagnosis. The less urban provinces had poorer access to diagnostic and staging modalities. Most facilities were able to provide breast-conserving surgery (79%), while fewer facilities could offer sentinel lymph node biopsy (SLNB) (53%) and still fewer could offer breast reconstruction (35%). Clinicians cited the foremost barriers to standard of care as advanced disease at diagnosis, inadequate access to surgical expertise and lack of access to essential equipment. The national average waiting time for surgery (28 days) is within the recommended timeframe from decision to treat. The representation of the multidisciplinary team across facilities does not comply with national staffing recommendations for a breast unit.
Conclusion. Broad disparities exist in access to essential staging and diagnostic modalities between facilities in different provinces. In many settings, there is limited capacity to provide key surgical interventions, particularly SLNB and breast reconstruction. These findings suggest that breast cancer care in most settings within the public healthcare sector is not concordant with proposed national guidelines. There is an urgent need to address the deficits in the distribution and capacity of breast cancer surgical services in SA.
References
1. Azubuike SO, Muirhead C, Hayes L, McNally R. Rising global burden of breast cancer: The case of sub-Saharan Africa (with emphasis on Nigeria) and implications for regional development: A review. World J Surg Oncol 2018;16(1):63. https://doi.org/10.1186/s12957-018-1345-2
2. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71(3):209-249. https:// doi.org/10.3322/caac.21660
3. Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): Analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet 2018;391:1023-1075. https://doi. org/10.1016/S0140-6736(17)33326-3
4. Rayne S, Burger S, van Straten S, Biccard B, Phaahla MJ, Smith M. Setting the research and implementation agenda for equitable access to surgical care in South Africa. BMJ Glob Health 2017;2(2):e000170. https://doi.org/10.1136/bmjgh-2016-000170
5. Bloom DE, Cafiero ET, Jané-Llopis, et al. The global economic burden of noncommunicable diseases. Geneva: World Economic Forum and Harvard School of Public Health, 2011. https://www3.weforum. org/docs/WEF_Harvard_HE_GlobalEconomicBurdenNonCommunicableDiseases_2011.pdf (accessed 27 May 2021).
6. McCormack V, McKenzie F, Foerster M, et al. Breast cancer survival and survival gap apportionment in sub-Saharan Africa (ABC-DO): A prospective cohort study. Lancet Glob Health 2020;8(9):e1203-e1212. https://doi.org/10.1016/S2214-109X(20)30261-8
7. National Department of Health, South Africa. Breast Cancer Prevention and Control Policy. Pretoria: NDoH, 2017. https://extranet.who.int/ncdccs/Data/ZAF_B5_breast cancer policy.pdf (accessed 19 April 2021).
8. Dey P, Bundred N, Gibbs A, et al. Costs and benefits of a one stop clinic compared with a dedicated breast clinic: Randomised controlled trial. BMJ 2002;324(7336):507. https://doi.org/10.1136/ bmj.324.7336.507
9. South Africa. National Health Act No. 61 of 2003. Government Gazette no. 35101. https://www.gov. za/sites/default/files/gcis_document/201409/35101rg9701gon185a.pdf (accessed 15 October 2022).
10. Humanitarian Data Exchange. Health facilities in sub-Saharan Africa. Humdata, 2020. https://data.
humdata.org/dataset/health-facilities-in-subsaharan-africa (accessed 22 August 2022).
11. Wikimedia Commons. South Africa 2016 population density by municipality. Wikimedia Commons, 2020. https://commons.wikimedia.org/wiki/File:South_Africa_2016_population_
density_by_municipality.svg (accessed 24 November 2022).
12. Ambroggi M, Biasini C, Del Giovane C, Fornari F, Cavanna L. Distance as a barrier to cancer diagnosis and treatment: Review of the literature. Oncologist 2015;20(12):1378-1385.
13. O’Neil DS, Chen WC, Ayeni O, et al. Breast cancer care quality in South Africa’s public health system: An evaluation using American Society of Clinical Oncology/National Quality Forum measures. J Glob Oncol 2019;5:1-16. https://doi.org/10.1200/JGO.19.00171
14. Knapp GC, Tansley G, Olasehinde O, et al. Geospatial access predicts cancer stage at presentation and outcomes for patients with breast cancer in southwest Nigeria: A population-based study. Cancer 2020;127(9):1432-1438. https://doi.org/10.1002/cncr.33394
15. Dickens C, Joffe M, Jacobson J, et al. Stage at breast cancer diagnosis and distance from diagnostic hospital in a periurban setting: A South African public hospital case series of over 1,000 women. Int J Cancer 2014;135(9):2173-2182. https://doi.org/10.1002/ijc.28861
16. Lince-Deroche N, Rensburg C, Masuku S, Rayne S, Benn C, Holele P. Breast cancer in South Africa: Developing an affordable and achievable plan to improve detection and survival. In: Health Systems Trust. South African Health Review 2017. Durban,: Health Systems Trust, 2017:181-188. https:// www.hst.org.za/publications/South%20African%20Health%20Reviews/17_Breast%20cancer%20 in%20South%20Africa_developing%20an%20affordable%20and%20achievable%20plan%20to%20 improve%20detection%20and%20survival.pdf (accessed 13 March 2026).
17. Sinha S, Bhatia R, Narasimamurthy M, Rayne S, Grover S. Epidemiology of breast cancer presentation in Botswana, South Africa, and the United States. J Surg Res 2022;279:5339. https://doi.org/10.1016/j. jss.2022.04.071
18. Sun L, Legood R, Dos-Santos-Silva I, Mathur Gaiha S, Sadique Z. Global treatment costs of breast cancer by stage: A systematic review. PLoS ONE 2018;13(11):e0207993. https://doi.org/10.1371/ journal.pone.0207993
19. Dalwai E, Buccimazza I. System delays in breast cancer. S Afr J Surg 2015;53(2):40-42. https://doi. org/10.7196/SAJSNEW.7741
20. Cubasch H, Joffe M, Ruff P, et al. Breast conservation surgery versus total mastectomy among women with localized breast cancer in Soweto, South Africa. PLoS ONE 2017;12(8):e0182125. https://doi. org/10.1371/journal.pone.0182125
21. Amouzou KS, Ketevi AA, Sambiani DM, Caroli A. Female breast cancer in sub-Saharan Africa: A PRISMA-S-compliant systematic review of surgery. J Surg Oncol 2022;125(3):336-351. https://doi. org/10.1002/jso.26720
22. Gu J, Groot G, Boden C, Busch A, Holtslander L, Lim H. Review of factors influencing women’s choice of mastectomy versus breast conserving therapy in early-stage breast cancer: A systematic review. Clin Breast Cancer 2018;18(4):539-554. https://doi.org/10.1016/j.clbc.2017.12.013
23. Groenewald C, Cubasch H, Mannell A, Ayeni O, Nietz S. Axillary lymph node dissection for patients with invasive breast cancer at Charlotte Maxeke and Chris Hani Baragwanath Academic Hospitals. S Afr J Surg 2019;57(4):18-24.
24. Dickens C, Duarte R, Zietsman A, et al. Racial comparison of receptor-defined breast cancer in Southern African women: Subtype prevalence and age-incidence analysis of nationwide cancer registry data. Cancer Epidemiol Biomarkers Prev 2014;23(1):2311-2321. https://doi.org/10.1158/1055- 9965.EPI-14-0603
25. Wiseman RJ, Riddin J, Jugathpal J, Parrish AG, Ruff P, Blockman M. Adjuvant trastuzumab in early HER2-positive breast cancer: Journeying towards the optimal duration of therapy in South Africa. S Afr Med J 2020;110(4):271-273. https://doi.org/10.7196/SAMJ.2020.v110i4.14621
26. McLaughlin JM, Anderson RT, Ferketich AK, Seiber EE, Balkrishnan R, Paskett ED. Effect on survival of longer intervals between confirmed diagnosis and treatment initiation among low-income women with breast cancer. J Clin Oncol 2012;30(36):4493-4500. https://doi.org/10.1200/JCO.2012.39.7695
27. Moodley J, Cairncross L, Naiker T, Constant D. From symptom discovery to treatment – women’s pathways to breast cancer care: A cross-sectional study. BMC Cancer 2018;18(1):312. https://doi. org/10.1186/s12885-018-4219-7
28. Foerster M, Anderson BO, McKenzie F, et al. Inequities in breast cancer treatment in sub-Saharan Africa: Findings from a prospective multi-country observational study. Breast Cancer Res 2019;21(1):93. https://doi.org/10.1186/s13058-019-1174-4
29. Sutter SA, Slinker A, Balumuka DD, Mitchell KB. Surgical management of breast cancer in Africa: A continent-wide review of intervention practices, barriers to care, and adjuvant therapy. J Glob Oncol 2016;3(2):162-168. https://doi.org/10.1200/JGO.2016.003095
30. Lambert M, Mendenhall E, Kim AW, Cubasch H, Joffe M, Norris SA. Health system experiences of breast cancer survivors in urban South Africa. Women Health 2020;16:1745506520949419. https://doi. org/10.1177/1745506520949419
Downloads
Published
Issue
Section
License
Copyright (c) 2026 L Milligan, L Roodt, F Malherbe, L Cairncross
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Licensing Information
The SAMJ is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
Publishing Rights
Authors grant the Publisher the exclusive right to publish, display, reproduce and/or distribute the Work in print and electronic format and in any medium known or hereafter developed, including for commercial use. The Author also agrees that the Publisher may retain in print or electronic format more than one copy of the Work for the purpose of preservation, security and back-up.
